Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up. [electronic resource]
Producer: 20011228Description: 549-54 p. digitalISSN:- 0090-8258
- Acyclovir -- pharmacokinetics
- Adenoviridae -- enzymology
- Adult
- Aged
- Antineoplastic Agents -- pharmacokinetics
- Antiviral Agents -- pharmacokinetics
- Combined Modality Therapy
- Enzyme Inhibitors -- pharmacokinetics
- Female
- Genetic Therapy -- methods
- Humans
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Second-Look Surgery
- Thymidine Kinase -- genetics
- Topotecan -- pharmacokinetics
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.